» Articles » PMID: 22386512

Asthma Outcomes: Biomarkers

Abstract

Background: Measurement of biomarkers has been incorporated within clinical research studies of asthma to characterize the population and associate the disease with environmental and therapeutic effects.

Objective: National Institutes of Health institutes and federal agencies convened an expert group to propose which biomarkers should be assessed as standardized asthma outcomes in future clinical research studies.

Methods: We conducted a comprehensive search of the literature to identify studies that developed and/or tested asthma biomarkers. We identified biomarkers relevant to the underlying disease process progression and response to treatment. We classified the biomarkers as either core (required in future studies), supplemental (used according to study aims and standardized), or emerging (requiring validation and standardization). This work was discussed at an National Institutes of Health-organized workshop convened in March 2010 and finalized in September 2011.

Results: Ten measures were identified; only 1, multiallergen screening to define atopy, is recommended as a core asthma outcome. Complete blood counts to measure total eosinophils, fractional exhaled nitric oxide (Feno), sputum eosinophils, urinary leukotrienes, and total and allergen-specific IgE are recommended as supplemental measures. Measurement of sputum polymorphonuclear leukocytes and other analytes, cortisol measures, airway imaging, breath markers, and system-wide studies (eg, genomics, proteomics) are considered as emerging outcome measures.

Conclusion: The working group participants propose the use of multiallergen screening in all asthma clinical trials to characterize study populations with respect to atopic status. Blood, sputum, and urine specimens should be stored in biobanks, and standard procedures should be developed to harmonize sample collection for clinical trial biorepositories.

Citing Articles

Association between monocyte-high-density lipoprotein cholesterol ratio and mortality in a population with asthma: a cohort study.

Zhang Q, Xia J, Zhuang R, Wen J, Wang C Lipids Health Dis. 2025; 24(1):59.

PMID: 39985043 PMC: 11844168. DOI: 10.1186/s12944-025-02484-y.


Relationship between systemic immune-inflammation index and long-term all-cause and cause-specific mortality among adult asthma patients: a population-based study.

Luo Z, Chen S, Zhu N, Qiu F, Huang W, Cao C BMC Pulm Med. 2024; 24(1):629.

PMID: 39709369 PMC: 11663310. DOI: 10.1186/s12890-024-03452-5.


Prenatal exposure to ambient fine particulate matter and child lung function in the CANDLE cohort.

Sherris A, Hazlehurst M, Dearborn L, Loftus C, Szpiro A, Adgent M Ann Med. 2024; 56(1):2422051.

PMID: 39492664 PMC: 11536642. DOI: 10.1080/07853890.2024.2422051.


Associations between vitamin D status and biomarkers linked with inflammation in patients with asthma: a systematic review and meta-analysis of interventional and observational studies.

El Abd A, Dasari H, Dodin P, Trottier H, Ducharme F Respir Res. 2024; 25(1):344.

PMID: 39322954 PMC: 11423515. DOI: 10.1186/s12931-024-02967-z.


Mitochondrial DNA copy number variation in asthma risk, severity, and exacerbations.

Xu W, Hong Y, Hu B, Comhair S, Janocha A, Zein J J Allergy Clin Immunol. 2024; .

PMID: 39237012 PMC: 11875079. DOI: 10.1016/j.jaci.2024.08.022.


References
1.
Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A . Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med. 2007; 176(3):238-42. DOI: 10.1164/rccm.200609-1346OC. View

2.
Hunt J, Yu Y, Burns J, Gaston B, Ngamtrakulpanit L, Bunyan D . Identification of acid reflux cough using serial assays of exhaled breath condensate pH. Cough. 2006; 2:3. PMC: 1459194. DOI: 10.1186/1745-9974-2-3. View

3.
Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D . Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J. 2005; 25(6):986-91. DOI: 10.1183/09031936.05.00132404. View

4.
Buchvald F, Hermansen M, Nielsen K, Bisgaard H . Exhaled nitric oxide predicts exercise-induced bronchoconstriction in asthmatic school children. Chest. 2005; 128(4):1964-7. DOI: 10.1378/chest.128.4.1964. View

5.
Westcott J, Maxey K, Macdonald J, Wenzel S . Immunoaffinity resin for purification of urinary leukotriene E4. Prostaglandins Other Lipid Mediat. 1998; 55(5-6):301-21. DOI: 10.1016/s0090-6980(98)00027-6. View